Raloxifene for primary and secondary prevention of osteoporotic fractures in postmenopausal women: a systematic review of effica

Printer-friendly version

Evaluates the safety and efficacy of raloxifene compared with placebo and other drugs approved in Canada for the primary and secondary prevention of osteoporotic vertebral fractures in postmenopausal women.